title: Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables.
abstract: OBJECTIVE
  The major concern about percutaneous transluminal coronary angioplasty (PTCA) is the high incidence of restenosis.
  
  
  METHODS
  Demographic, clinical and biochemical data were recorded 2 weeks prior to PTCA in 388 patients fulfilling the criteria for initial stenosis, successful PTCA, and angiographic follow-up after 6 months. Restenosis was evaluated by quantitative coronary angiography.
  
  
  RESULTS
  Variables predictive of restenosis in univariate analysis were diabetes mellitus, male gender, and the levels of high density lipoprotein (HDL) cholesterol, apolipoprotein A1 (Apo A1) and thio-barbituric acid-reactive substances (TBARS). In trend analysis through quartiles TBARS and fasting glucose levels were significantly associated with restenosis (p = 0.016 and 0.044, respectively), whereas the negative predictivity of Apo A1 and HDL-cholesterol were of borderline significance. In multivariate analysis male gender and diabetes mellitus showed predictivity of significance, and a negative predictivity was also apparent for HDL-cholesterol.
  
  
  CONCLUSIONS
  We conclude that diabetes mellitus, male gender, and low HDL-cholesterol are predictors of restenosis 6 months after PTCA. In addition, TBARS may be a marker for the development of restenosis after PTCA.
authors.affiliation: Department of Cardiology, Ullevaal University Hospital, Oslo, Norway. odd.johansen@ioks.uio.no
authors.forename: O
authors.initials: O
authors.lastname: Johansen
authors.forename: M
authors.initials: M
authors.lastname: Abdelnoor
authors.forename: M
authors.initials: M
authors.lastname: Brekke
authors.forename: I
authors.initials: I
authors.lastname: Seljeflot
authors.forename: A T
authors.initials: AT
authors.lastname: Høstmark
authors.forename: H
authors.initials: H
authors.lastname: Arnesen
mesh_terms: D000328:Adult; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D015331:Cohort Studies; D017023:Coronary Angiography; D003327:Coronary Disease / Q000097:blood* / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D048909:Diabetes Complications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D012008:Recurrence; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D008055:Lipids